This review discusses chronic pain, multiple modifiable lifestyle factors, such as stress,
insomnia, diet, obesity, smoking, alcohol consumption and physical activity, and the …

Chemotherapy-induced peripheral neurotoxicity (CIPN) is a major dose-limiting side effect of
many anti-cancer agents, including taxanes, platinums, vinca alkaloids, proteasome …

Background: This systematic review and meta-analysis aimed to determine whether
chemotherapy-induced peripheral neuropathy (CIPN) affects the risk of falls and physical …

Background To identify the association between diabetes mellitus (DM) and the risk of
chemotherapy-induced peripheral neuropathy (CIPN) through a systematic review and meta …

Identifying patients at higher risk of chemotherapy-induced peripheral neuropathy (CIPN) is
a major unmet need given its high incidence, persistence, and detrimental effect on quality …

Background Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and
dose-limiting side effect of systemic cancer therapy. In many cancer survivors, CIPN persists …

Objective This paper aims to provide an evidence-based summary of the most effective
strategies for comprehensive healthcare of chemotherapy-induced peripheral neuropathy …

Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is a major side effect of
neurotoxic cancer treatment, often impacting treatment tolerability and patient functioning …

Purpose Peripheral neuropathy adversely affects the treatment process of cancer, and thus it
is important to reveal the factors leading to peripheral neuropathy and to take the necessary …

Background Cancer patients treated with neurotoxic chemotherapy are at risk of develo**
neurological symptoms that can impact functional capacity and quality of life. However, there …